Giannarelli Chiara, De Negri Ferdinando, Virdis Agostino, Ghiadoni Lorenzo, Cipriano Alessandro, Magagna Armando, Taddei Stefano, Salvetti Antonio
Department of Internal Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, Italy.
Hypertension. 2007 Apr;49(4):878-84. doi: 10.1161/01.HYP.0000260471.16113.d8. Epub 2007 Mar 5.
We evaluated the possible role of NO in modulating tissue plasminogen activator (t-PA) release in the forearm microcirculation of normotensive subjects and hypertensive patients. Essential hypertensive patients are characterized by endothelial dysfunction because of a reduced NO availability and also show an impaired t-PA release. In healthy volunteers and essential hypertensive patients, we studied local t-PA release and forearm blood flow changes (strain-gauge plethysmography) induced by intrabrachial administration of acetylcholine (0.45 and 1.5 microg/100 mL/min) and of sodium nitroprusside (0.5 and 1.0 microg/100 mL/min), an endothelium-dependent and -independent agonist, respectively. Acetylcholine was also repeated in the presence of intra-arterial infusion of the NO synthase inhibitor N(G)-monomethyl-l-arginine (100 microg/100 mL/min). In normotensive subjects, vasodilation to acetylcholine was blunted by N(G)-monomethyl-l-arginine. In these subjects, acetylcholine infusion induced a significant, dose-dependent increase in net forearm t-PA release. N(G)-monomethyl-l-arginine significantly reduced basal t-PA release, as well as acetylcholine-induced t-PA release. In essential hypertensive patients, vasodilation to acetylcholine was reduced as compared with controls and resistant to N(G)-monomethyl-l-arginine. In contrast to what was observed in healthy control subjects, in hypertensive patients, acetylcholine had no effect on t-PA release. Similarly, N(G)-monomethyl-l-arginine failed to modify either the tonic or the agonist-induced t-PA release. Both tonic and agonist-induced release of NO are directly involved in t-PA release by endothelial cells. Essential hypertension, characterized by a reduction in tonic and stimulated NO availability, is also associated with impaired capacity of t-PA release, suggesting a major role of impaired NO availability in worsening both vasodilation and t-PA release.
我们评估了一氧化氮(NO)在调节血压正常受试者和高血压患者前臂微循环中组织纤溶酶原激活物(t-PA)释放方面的潜在作用。原发性高血压患者的特征是由于NO可用性降低导致内皮功能障碍,并且t-PA释放也受损。在健康志愿者和原发性高血压患者中,我们研究了通过肱动脉内给予乙酰胆碱(0.45和1.5微克/100毫升/分钟)和硝普钠(0.5和1.0微克/100毫升/分钟)分别诱导的局部t-PA释放和前臂血流变化(应变片体积描记法),乙酰胆碱是内皮依赖性激动剂,硝普钠是内皮非依赖性激动剂。在动脉内输注NO合酶抑制剂N(G)-单甲基-L-精氨酸(100微克/100毫升/分钟)的情况下,也重复给予乙酰胆碱。在血压正常的受试者中,N(G)-单甲基-L-精氨酸使对乙酰胆碱的血管舒张作用减弱。在这些受试者中,输注乙酰胆碱诱导前臂净t-PA释放显著的剂量依赖性增加。N(G)-单甲基-L-精氨酸显著降低基础t-PA释放以及乙酰胆碱诱导的t-PA释放。在原发性高血压患者中,与对照组相比,对乙酰胆碱的血管舒张作用降低,并且对N(G)-单甲基-L-精氨酸有抗性。与在健康对照受试者中观察到的情况相反,在高血压患者中,乙酰胆碱对t-PA释放没有影响。同样,N(G)-单甲基-L-精氨酸未能改变紧张性或激动剂诱导的t-PA释放。紧张性和激动剂诱导的NO释放均直接参与内皮细胞的t-PA释放。原发性高血压的特征是紧张性和刺激后的NO可用性降低,也与t-PA释放能力受损有关,这表明NO可用性受损在血管舒张和t-PA释放恶化中起主要作用。